Why AARD? Aardvark Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
AARD
$5.66+0.19 (+3.38%)
Market OpenUpdated 1:22 PM EDT
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.